Which has the lower trailing P/E, EW or WAT?

EW has the lower trailing P/E: EW trades at 49.59 and WAT at 108.11. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, EW or WAT?

Over the past five years, WAT grew revenue faster — EW at a 5.75% CAGR versus WAT at 11.70%.

Is EW or WAT more profitable?

EW runs the higher net margin — EW at 15.43% versus WAT at 3.58%.

How have EW and WAT total returns compared?

Over the past 10 years, EW delivered 8.24% and WAT delivered 10.36% annualized total return. Past performance doesn't predict future results.

Edwards Lifesciences Corporation (EW) vs Waters Corporation (WAT)

A side-by-side comparison of Edwards Lifesciences Corporation and Waters Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

Edwards Lifesciences Corporation

$49.69B

$86.29HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

WAT

Waters Corporation

$42.57B

$433.54HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

Total return — EW vs WAT

growth of $100 · dividends reinvested · last 10y

EW +130.6% (+8.7%/yr)WAT +154.2% (+9.8%/yr)WAT compounded faster over this window

EW WAT

EW vs WAT: by the numbers

•EW is the larger company ($49.69B vs $42.57B market cap).
•EW trades at the lower trailing earnings multiple (49.59 vs 108.11 P/E), one valuation lens rather than an overall verdict.
•EW converts more revenue to profit (15.43% vs 3.58% net margin).
•WAT grew revenue faster over the past five years (11.70% vs 5.75% CAGR).

Metrics side by side

Valuation

Metric	EW	WAT
P/E ratio	49.59	108.11
Forward P/E	28.75	29.75
P/S ratio	7.63	9.17
P/B ratio	4.68	2.80
EV / EBITDA	23.80	50.96
FCF yield	2.89%	0.94%

Profitability

Metric	EW	WAT
Gross margin	77.98%	50.78%
Operating margin	28.09%	28.22%
Net margin	15.43%	3.58%
ROE	9.46%	1.09%
ROIC	10.22%	1.34%

Growth (annualized)

Metric	EW	WAT
Revenue CAGR (5Y)	5.75%	11.70%
EPS CAGR (5Y)	6.87%	5.16%
FCF CAGR (5Y)	6.41%	-9.10%
Total return CAGR (5Y)	-6.94%	-0.83%

Frequently asked

Which has the lower trailing P/E, EW or WAT?: EW has the lower trailing P/E: EW trades at 49.59 and WAT at 108.11. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, EW or WAT?: Over the past five years, WAT grew revenue faster — EW at a 5.75% CAGR versus WAT at 11.70%.
Is EW or WAT more profitable?: EW runs the higher net margin — EW at 15.43% versus WAT at 3.58%.
How have EW and WAT total returns compared?: Over the past 10 years, EW delivered 8.24% and WAT delivered 10.36% annualized total return. Past performance doesn't predict future results.

Go deeper

Full EW analysis Full WAT analysis Interactive comparison tool

Dig into the metrics

Edwards Lifesciences P/E ratio Waters P/E ratio Edwards Lifesciences ROE Waters ROE Edwards Lifesciences operating margin Waters operating margin Edwards Lifesciences revenue growth Waters revenue growth Edwards Lifesciences free cash flow Waters free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.